The study yielded numerous important findings [ Figure 1 ]: (1) PM 2.5 exposure promotes hypertriglyceridemia and hepatic steatosis in NC-fed mice, while PM 2.5 exposure reduces hepatic injury, hyperlipidemia, and hepatic steatosis in obese, HF-fed mice; (2) The reduction in steatosis and hyperlipidemia was due to induction of autophagy by PM 2.5 ; (3) The hepatic autophagy induced by PM 2.5 is reliant upon myeloid differentiation primary response 88 (MyD88), the primary mediator of toll-like receptor-mediated inflammatory signaling. The results of this study are significant for better understanding the mechanistic basis by which ambient PM 2.5 pollution, in combination with other stressors, can modulate pathophysiology.
The study revealed the underlying mechanism by which PM 2.5 can reduce hepatic steatosis. Hepatic autophagy is activated by exposure to inhaled PM 2.5 . Autophagy has important protective metabolic functions, including maintenance of insulin sensitivity and degradation of intracellular lipids, under metabolic conditions, such as obesity or HF feeding. [2, 3] Obesity induced by a HF diet decreases hepatic autophagy. Decreased autophagy is a major factor involved in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). [4, 5] The study indicated that PM 2.5 exposure also triggered hepatic autophagy in mice fed with NC. However, the NC mice displayed hepatic steatosis due to the repression of lipolysis and fatty acid oxidation by PM 2.5 . The anti-lipolytic and anti-fatty acid oxidative effects of PM 2.5 exposure overrode the effect of hepatic autophagy in these mice. In contrast, the HF-fed mice experienced a reduction in hepatic steatosis because their initial levels of hepatic autophagy were reduced. In these mice, hepatic autophagy induced by PM 2.5 negated the suppressive effect of HF feeding on autophagy and possibly, other metabolic pathways. The anti-lipolytic and anti-fatty acid oxidative effects of PM 2.5 were overweighed by its induction of fat-reducing lipophagy. Therefore, PM 2.5 exposure alleviated liver injury, reduced hepatic steatosis, and reduced hyperlipidemia in HF-fed mice.
This study raised an interesting question: Is PM 2.5 a double-edged sword? Does PM 2.5 exposure promote or relieve hepatic steatosis under NC or HF diet? It may suggest that individuals with obesity or NAFLD resulting from HF diet or "Western-style" diet under clean air environments can gain health benefits by living in areas under high levels of ambient PM 2.5 (such as China and India) for a designated period. However, future studies are required to determine if the proposed anti-hepatic steatosis and anti-hyperlipidemia effects are enough to overcome the detrimental health effects of exposure to airborne pollution. The mice in the study were exposed to 111.0 µg/m 3 of PM 2.5 . Recent studies have shown a decrease in 1.10 cardiovascular-related deaths per 100,000 individuals for every 1 µg/m 3 decrease in PM 2.5 . [6] Studies in which varied concentrations of PM 2.5 exposure are examined against hepatic steatosis in HF-fed mice may begin to elucidate the point at which PM 2.5 effectively achieves the observed outcomes of this study. Furthermore, the ratio of prior-exposure PM 2.5 level to experimental PM 2.5 level may be useful in determining if a therapeutic relationship exists. Future studies may also analyze exposure time required to obtain the outcomes observed in the study. Specifically, does shorter exposure time yield similar benefits? How does longer exposure time affect hyperlipidemia and steatosis?
The study conducted by Qiu et al. was well considered and thought provoking. PM 2.5 indeed proves to be a double-edged sword in determining how therapeutic benefits might be obtained from a current public health dilemma.
